Elevated levels of EIF3B have been linked to poor prognosis in clear cell renal cell carcinoma [26], esophageal squamous cell carcinoma [27], gastric cancer [28], and bladder cancer [29]. Here, EIF3B is linked to urinary bladder cancer.